These reports suggest that NHE1 is a molecule that plays an essential role in the pathogenesis of DM-HFrEF and has potential as a novel target of therapeutic strategies for DM-HFrEF; however, this mechanism remains controversial16,17. This evidence concerns the gene SLC9A1 and diabetes mellitus.